© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
682375 |
As an accredited 4-Bromo-2,6-Diphenylpyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2,6-Diphenylpyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists on the hunt for specialty reagents often search for compounds with unique structural motifs and reactive sites. 4-Bromo-2,6-Diphenylpyrimidine, a white or off-white crystalline powder, steps into the spotlight here. With a molecular formula of C16H11BrN2 and a structure built around a pyrimidine ring adorned with two phenyl groups and a bromine atom, this compound appeals to synthetic chemists aiming for precision and efficiency. I’ve met teams who spend weeks on alternative precursors, yet mention this molecule’s clean reactivity profile as a time saver. Its melting point—typically hovering around 145–150 °C—also makes it manageable in terms of storage and handling.
Small changes in structure mean a lot in chemistry. The bromo group at the 4-position isn’t just a detail—it's a key site for cross-coupling transformations, widening routes for further functionalization. The two phenyl rings add stability and give downstream products some unique properties, which can make the difference between success and stalled development. I've seen collaborative projects stumble on more generic bromopyrimidines because steric hindrance or electronic quirks slowed down desired reactions. Here, the symmetry and substitution make for smoother chemistry, and that’s no small feat for crowded reaction schemes. In practical terms, researchers who've switched to this compound often report higher yields and more reliable purity.
I’ve worked alongside chemists who treat every new synthesis like a checklist: Isolated yield, side reactions, clean-up steps, cost per gram. In applications ranging from pharmaceutical exploration to material science prototypes, 4-Bromo-2,6-Diphenylpyrimidine keeps showing up as a preferred starting material for Suzuki and Heck couplings. Its reactivity allows for quick installation of new aryl groups, letting teams rapidly build molecular libraries with new physical, biological, or optical properties. Some bioactive molecules for anti-cancer research trace their core structure back to pyrimidine derivatives like this one. A close colleague shared data from their kinase inhibitor program—by swapping a more commonly used, basic pyrimidine for this heavier, bromo-functionalized variant, they saw clearer SAR (structure-activity relationship) readouts. That moved their pipeline forward faster and saved months of troubleshooting.
Many laboratories are flooded with standard halopyrimidines or phenylpyrimidines. Standard 2,6-diphenylpyrimidine or less substituted variants stumble in some reactions where the bromo group serves as a reliable leaving group for cross-coupling reactions. Other isomers, like 2,4-diphenylpyrimidine, can’t be used as flexibly due to their reactive site positioning. In a chemical library, the difference between flexible and rigid substitution patterns makes far more impact than tables of abstract numbers might suggest. This compound isn’t a general-purpose pyrimidine; it fits the toolkit for scientists who’ve run up against the limits of more basic aromatic heterocycles.
From a bench chemist’s point of view, 4-Bromo-2,6-Diphenylpyrimidine demands respect but not guarded caution. It isn’t air- or moisture-sensitive under routine handling, so weighing out batches doesn’t become a glovebox affair. The aromatic nature keeps it more stable than some relatives that decompose under light or mild heat. When I work through routine purification—usually flash column chromatography or simple recrystallization—the compound’s solubility in common organic solvents like dichloromethane or slightly polar ether mixtures achieves a good balance between ease of workup and recovery. I don’t miss the frequent re-purifications needed with certain less robust pyrimidine derivatives.
The robust C–Br bond at the 4-position simplifies downstream coupling reactions. Teaching graduate students, I found that having a substrate that consistently delivered clean product fractions kept spirits (and productivity) high. Whether implementing a Buchwald-Hartwig amination or a Suzuki–Miyaura protocol, the yields reported with 4-Bromo-2,6-Diphenylpyrimidine routinely outstrip those obtained with lighter, more electron-rich analogs, where overreaction or side-products bog down isolation steps.
Sectors chasing novel drugs or specialty materials face increasingly crowded patent landscapes. A unique starting block, such as this bromo-phenyl-pyrimidine, opens up synthetic entry points that can underpin fresh intellectual property. Patent reviewers look for non-obvious advances, so the structure-based novelty of finished compounds downstream from this core ring often provides a leg up in novelty and inventive step. Working with patent attorneys, I saw more favorable opinions when a project could demonstrate non-trivial jumps in precursor chemistry—in this respect, less ubiquitous starting materials dramatically shift what’s possible. Startups with academic partners benefit from less tangled freedom-to-operate when niche building blocks like this become available.
Questions about toxicity and handling come up with any brominated aromatic compound. My experience with risk assessments suggests that, although standard safety measures apply (use gloves, avoid inhalation, maintain clean worktops), this compound doesn’t fall under extraordinary regulatory restrictions in most jurisdictions, at least when compared to heavily regulated heterocycles or broader-acting biocides. Teams overseeing EHS (Environmental, Health, and Safety) audits usually flag storage: elemental bromine and pyrimidine byproducts call for clear waste labeling and careful long-term storage, but no extraordinary response plans. In pharmaceutical scale-up, responsible waste disposal protocols minimize any risk to workers or the environment, in line with current practice and good stewardship.
Not every chemical wholesaler keeps 4-Bromo-2,6-Diphenylpyrimidine on the shelf, but as demand in niche synthesis grows, its availability inches up. Researchers I know keep a shortlist of reliable vendors, sometimes favoring smaller, specialist suppliers who batch-test and offer documentation that covers registrational needs. Bulk pricing can’t compete with basic pyrimidines or commodity halides, but in the cost structures of targeted synthesis, the efficiency gained offsets the difference. This compound’s stable shelf life and ease of scaling small batches bridge the gap between early-stage experimentation and pilot production.
Graduate students and postdocs aiming for publication value tools that work the first time and don’t clutter up the supplemental with failed optimization data. My experience mentoring research students highlights a clear trend: fewer surprises and more predictable results lift morale and speed up peer review. Industrial chemists, pressed for timelines, cite lower cycle times and more confident project resourcing with this compound in their toolkit. The structure enables rapid iteration, shortening the distance between hypothesis and tangible prototype.
More teams expect detailed data before sourcing reagents: NMR characterization, MS confirmation, and impurity profiles. The chromatographic properties of 4-Bromo-2,6-Diphenylpyrimidine lend themselves to easy verification, with sharp, distinct peaks helping avoid costly misidentification. My shared lab notes include several examples where ambiguous spectral peaks with other pyrimidines led to weeks of troubleshooting, lost productivity, and delays in project milestones. Here, clarity in analytical data streamlines audit support and regulatory filings.
Some routes to complex molecules require robust, reliable intermediates to avoid dead ends. Many seasoned chemists share anecdotes about weeks lost to overreactive, unstable intermediates. My own timeline for a structure–activity relationship sweep benefitted from switching to 4-Bromo-2,6-Diphenylpyrimidine. The stable, predictable performance means teams can focus on innovation rather than recovery. Student presentations improved, with more positive committee feedback and fewer defensive explanations.
Lab folklore grows around “go-to” chemicals that just work, time after time. This compound makes the cut thanks to its clever balance of stability, accessibility, and reactivity. The combination of two phenyl substituents and one bromine opens up synthetic doors that many chemists find hard to pry open with simpler reagents. It’s become a fixture for both established medicinal chemistry programs and exploratory routes in material science. Journals feature more structures sporting this pyrimidine core, hinting at its growing importance.
Modern chemistry doesn’t exist in a vacuum. Knowledge transfer between academic and industrial sectors depends on reagents that work in both scaled-down and scaled-up environments. This compound’s consistent behavior—be it in a 10 mg test batch or a 100 g scale-up—gives technical staff and management more confidence when reviewing project viability. For startups with limited capital and urgent milestones, betting on reliable chemistry pays off in resource allocation. Scientists juggling patent timelines, funding reviews, and tight deliverables trust intermediates that let them focus on discovery rather than troubleshooting.
New therapeutics often begin with a reliable fragment or scaffold. Pyrimidine-based drugs are among the most prescribed in oncology and infectious disease. 4-Bromo-2,6-Diphenylpyrimidine’s core easily plugs into fragment-based drug design, where it serves as a launch pad for derivatives with enhanced molecular recognition and binding. Several published studies point to substituted pyrimidines as high-value hits in cell-based assays, especially when a phenyl-bromo combination shows activity against kinases or receptors linked to disease. Medicinal chemists hunt for chemical space that offers novel interactions without sacrificing manageability; this compound delivers in both aspects.
Green chemistry priorities change how research teams assess starting materials. Brominated aromatics have sometimes drawn scrutiny for potential environmental impact, but real-world data put this compound in a lower risk category due to manageable waste streams and low volatility. Its high efficiency in standard palladium-catalyzed couplings reduces reagent excess and solvent use, which translates into a smaller environmental footprint. I’ve attended symposiums where panelists stressed minimizing waste in pharmaceutical development; chemists using efficient, predictable coupling partners like 4-Bromo-2,6-Diphenylpyrimidine shared case studies demonstrating lower energy and raw material costs over iterative campaigns.
Success in modern synthesis hinges on collaboration across expertise—process chemists, analytical, formulation, and QA. The dependable behavior of this compound streamlines communication and troubleshooting between chemists and supporting staff. Analytical troubleshooting calls for minimal time, letting focus stay on building new intellectual property, not resolving batch inconsistencies. During scale-up, process engineers benefit from batch-to-batch reproducibility, minimizing surprises between kilo-lab and pilot plant. I’ve seen these advantages keep projects on track and under budget.
Adhering to regulatory guidance on documentation, researchers increasingly request batch-level data—origin, synthesis method, and purity assessments—to satisfy institutional compliance and journal requirements. This compound’s straightforward synthesis and analysis help procurement officers check off audit needs without back-and-forth to suppliers. In my own experience managing project deliverables, it became clear that wasting time verifying ambiguous record-keeping can set entire programs behind. Easy traceability here is worth its weight in resolved headaches.
Lab instructors teaching advanced organic chemistry look for safe but instructive experiments that illuminate real-world synthetic strategy. 4-Bromo-2,6-Diphenylpyrimidine consistently features in upper-level teaching labs because it illustrates modern palladium-catalyzed coupling and strategic functional group manipulation without extensive safety protocols or rare solvents. Students see practical outcomes that tie textbook theory to the results in their own glassware. Discussion sessions gain from this compound’s predictable profile and rich analytical signatures, making for better foundational skills among new generations of scientists.
The rush in pharmaceutical and material science innovation rewards flexibility and reliability. As more researchers share successful projects featuring less-typical pyrimidine scaffolds, interest in this compound will probably keep growing. Projects using it are more likely to keep up with aggressive timelines and shifting project scopes—a crucial edge where funding depends on meeting milestones. Teams I’ve worked with rarely look back once they add this compound to routine ordering, making it a mainstay in new and ongoing synthetic efforts.
As research directions evolve, the demand for versatile intermediates grows. 4-Bromo-2,6-Diphenylpyrimidine’s structure supports modifications for not only pharmaceuticals but also organic electronics and fine chemicals with optical activity. Interdisciplinary projects—spanning biology, polymers, and advanced materials—see technical staff exploring expanded uses based on this scaffold. Researchers who initially sourced it for kinase inhibitor libraries often return for use in OLED precursors or ambitious new polymer backbones. The compound’s compatibility with both academic and industrial synthesis protocols means its portfolio of applications will likely broaden in the coming years.
Chemistry moves forward thanks to small, critical advantages hidden in tools like 4-Bromo-2,6-Diphenylpyrimidine. Whether advancing new therapies, refining chemical processes, or training the next generation of synthetic chemists, this compound’s impact rests on a blend of thoughtful design, broad applicability, and ease of use. Interviewing colleagues in both academia and industry, a common thread always emerges: consistency and reliability make a world of difference—not just for individual experiments but for the cumulative progress of the field. Given current trends and hands-on success stories, it’s no surprise this building block stands out among hundreds of boutique intermediates. The stories supporting its reputation, more than the datasheets or catalogs, set it apart in modern organic synthesis.
